发明公开
EP1203586A3 Compositions comprising a mast cell degranulation-blocking agent for treatment of endogenous, painful gastrointestinal conditions of non-inflammatory, non-ulcerative origin. 失效
含有肥大细胞脱粒粘连剂,内源性的处理组合物,疼痛的胃肠道症状与非炎性,非溃疡性原点

  • 专利标题: Compositions comprising a mast cell degranulation-blocking agent for treatment of endogenous, painful gastrointestinal conditions of non-inflammatory, non-ulcerative origin.
  • 专利标题(中): 含有肥大细胞脱粒粘连剂,内源性的处理组合物,疼痛的胃肠道症状与非炎性,非溃疡性原点
  • 申请号: EP02075270.5
    申请日: 1995-02-09
  • 公开(公告)号: EP1203586A3
    公开(公告)日: 2002-10-30
  • 发明人: Theoharides, Theohans C.
  • 申请人: KOS PHARMACEUTICALS, INC.
  • 申请人地址: Suite 2502, 1001 Brickell Bay Drive Miami, FL 33131 US
  • 专利权人: KOS PHARMACEUTICALS, INC.
  • 当前专利权人: KOS PHARMACEUTICALS, INC.
  • 当前专利权人地址: Suite 2502, 1001 Brickell Bay Drive Miami, FL 33131 US
  • 代理机构: Mercer, Christopher Paul
  • 优先权: US193597 19940209
  • 主分类号: A61K31/417
  • IPC分类号: A61K31/417 A61P1/06
Compositions comprising a mast cell degranulation-blocking agent for treatment of endogenous, painful gastrointestinal conditions of non-inflammatory, non-ulcerative origin.
摘要:
A method for treating endogenous, painful gastrointestinal condition of non-inflammatory, non-ulcerative origin, such as abdominal migraine and irritable bowel syndrome, entails administering a pharmacologically effective amount of a mast cell degranulation-blocking agent, e.g. a histamine-3 receptor agonist.
信息查询
0/0